Literature DB >> 24598619

Prenatal-screening companies expand scope of DNA tests.

Erika Check Hayden.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24598619     DOI： 10.1038/507019a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

1.  Reproductive genetic testing and human genetic variation in the era of genomic medicine.

Authors:  Chelsea Lowther; Gregory Costain; Anne S Bassett
Journal:  Am J Bioeth       Date:  2015       Impact factor: 11.229

2.  Technological advances in precision medicine and drug development.

Authors:  Elaine Maggi; Nicole E Patterson; Cristina Montagna
Journal:  Expert Rev Precis Med Drug Dev       Date:  2016-05-05

3.  Informed decision-making about prenatal cfDNA screening: An assessment of written materials.

Authors:  Marsha Michie; Stephanie A Kraft; Mollie A Minear; Roberta R Ryan; Megan A Allyse
Journal:  Ethics Med Public Health       Date:  2016-09-13

4.  Identification of a de novo fetal variant in osteogenesis imperfecta by targeted sequencing-based noninvasive prenatal testing.

Authors:  Xiuju Yin; Yang Du; Han Zhang; Zhandong Wang; Juan Wang; Xinxin Fu; Yaoyao Cui; Chongjian Chen; Junbin Liang; Zhaoling Xuan; Xiaohong Zhang
Journal:  J Hum Genet       Date:  2018-08-21       Impact factor: 3.755

5.  Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.

Authors:  Wybo Dondorp; Guido de Wert; Yvonne Bombard; Diana W Bianchi; Carsten Bergmann; Pascal Borry; Lyn S Chitty; Florence Fellmann; Francesca Forzano; Alison Hall; Lidewij Henneman; Heidi C Howard; Anneke Lucassen; Kelly Ormond; Borut Peterlin; Dragica Radojkovic; Wolf Rogowski; Maria Soller; Aad Tibben; Lisbeth Tranebjærg; Carla G van El; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

Review 6.  Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues.

Authors:  Jean Gekas; Sylvie Langlois; Vardit Ravitsky; François Audibert; David Gradus van den Berg; Hazar Haidar; François Rousseau
Journal:  Appl Clin Genet       Date:  2016-02-04

7.  Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies.

Authors:  Michael Zeisberg; Elisabeth M Zeisberg
Journal:  Fibrogenesis Tissue Repair       Date:  2015-09-01

8.  Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression.

Authors:  Chelsea Lowther; Marsha Speevak; Christine M Armour; Elaine S Goh; Gail E Graham; Chumei Li; Susan Zeesman; Malgorzata J M Nowaczyk; Lee-Anne Schultz; Antonella Morra; Rob Nicolson; Peter Bikangaga; Dawa Samdup; Mostafa Zaazou; Kerry Boyd; Jack H Jung; Victoria Siu; Manjulata Rajguru; Sharan Goobie; Mark A Tarnopolsky; Chitra Prasad; Paul T Dick; Asmaa S Hussain; Margreet Walinga; Renske G Reijenga; Matthew Gazzellone; Anath C Lionel; Christian R Marshall; Stephen W Scherer; Dimitri J Stavropoulos; Elizabeth McCready; Anne S Bassett
Journal:  Genet Med       Date:  2016-05-19       Impact factor: 8.822

9.  Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.

Authors:  Olivia Miu Yung Ngan; Huso Yi; Shenaz Ahmed
Journal:  BMC Health Serv Res       Date:  2018-09-21       Impact factor: 2.655
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.